Barclays PLC Chembio Diagnostics, Inc. Transaction History

Barclays PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.09 - $2.55 $2,571 - $6,015	-2,359 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.06 - $5.34 $3,909 - $10,135	-1,898 Reduced 44.59%	2,359 $6,000
Q2 2021 Aug 13, 2021	SELL	$2.88 - $5.64 $35,305 - $69,140	-12,259 Reduced 74.22%	4,257 $12,000
Q1 2021 May 13, 2021	BUY	$3.4 - $7.97 $34,479 - $80,823	10,141 Added 159.07%	16,516 $58,000
Q4 2020 Feb 11, 2021	SELL	$4.11 - $7.51 $10,673 - $19,503	-2,597 Reduced 28.95%	6,375 $31,000
Q3 2020 Nov 12, 2020	SELL	$3.28 - $5.93 $90,058 - $162,820	-27,457 Reduced 75.37%	8,972 $43,000
Q2 2020 Aug 12, 2020	BUY	$3.18 - $15.54 $115,844 - $566,106	36,429 New	36,429 $119,000
Q4 2019 Feb 10, 2020	SELL	$3.94 - $5.76 $417 - $610	-106 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.84 - $7.25 $513 - $768	106 New	106 $0
Q4 2018 Feb 14, 2019	SELL	$4.95 - $10.5 $19 - $42	-4 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.2 - $11.5 $36 - $46	4 New	4 $0

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.